CROYDON HEALTH SERVICES NATIONAL HEALTH SERVICE TRUST

Their core work

Croydon Health Services NHS Trust is an acute and community NHS hospital trust serving south London, responsible for delivering frontline healthcare to a population of around 400,000. In the EU research context, the Trust contributes real-world clinical environments, patient data governance expertise, and operational healthcare knowledge that technology developers cannot replicate in a lab. Their H2020 participation spans two distinct roles: as an end-user validating health big data analytics platforms in live care settings, and as a practitioner stakeholder ensuring that cybersecurity frameworks are grounded in the actual informatics realities of a busy NHS environment. This makes them a valuable bridge between research technology and clinical deployment.

What they specialise in

How they've shifted over time

In their first H2020 project (2015–2018), CHS focused on the opportunity side of digital health: using big data analytics to improve integrated care, visualise patient journeys, and accelerate service delivery. By their second project (2020–2023), the focus had shifted decisively to the risk side: protecting that same health data infrastructure through threat hunting, secure data management, and resilience benchmarking. This is a logical and telling progression — first you build the data-driven health system, then you have to defend it. The shift mirrors a broader NHS and EU policy trajectory toward mandatory cybersecurity standards for health data environments.

CHS is moving from being a validator of digital health tools toward being a practitioner voice in healthcare security — a niche that will grow in importance as NHS digital transformation accelerates and NIS2-style regulations tighten across Europe.

How they like to work

CHS participates exclusively as a consortium partner, never as a project coordinator — a pattern typical of clinical end-users who contribute real-world validation rather than technical development. Their network of 30 unique partners across 14 countries from just two projects suggests they join well-connected, multi-stakeholder consortia rather than small focused teams. For a prospective partner, this means CHS brings authentic NHS operational context and credibility, but the relationship will be practitioner-to-researcher rather than equal technical collaborators.

Despite only two projects, CHS has connected with 30 unique consortium partners spanning 14 countries, reflecting their participation in large, pan-European research consortia typical of H2020 ICT and security calls. Their network is broadly European with no apparent geographic concentration beyond their UK base.

What sets them apart

CHS occupies a rare niche in EU research consortia: a real, large-scale NHS acute trust that can provide live clinical validation environments, authentic patient data governance constraints, and frontline operational credibility that no university hospital or research lab can fully replicate. Researchers building health data or cybersecurity tools need NHS partners to demonstrate real-world applicability — CHS offers exactly that access, along with the institutional weight of a regulated public health authority. For consortia targeting UK or NHS deployment pathways, CHS is particularly valuable as a named end-user partner.

Highlights from their portfolio

• HEIR
  Addresses the intersection of cybersecurity and healthcare informatics resilience — a high-priority and fast-growing area as health systems face increasing ransomware and data breach threats, and one where NHS trusts carry significant regulatory exposure.
• AEGLE
  The larger of the two grants (EUR 355,625) and CHS's entry into EU research, establishing their profile as an NHS end-user capable of validating integrated analytics platforms at scale in a live hospital environment.